ACCURADX

Welcome to the Brand page for “ACCURADX”, which is offered here for Downloadable computer software that is focusing on bioinformatics analyses of ngs data for research use only and/or medical?diagnostic purposes via laboratory-developed tests (ldts) and fda-approved in vitro diagnostics (ivds);genetics, genomics and epigenomics-related reagents for medical diagnostic purposes via laboratory-developed tests (ldts) and fda-approved in vitro diagnostics (ivds);acura dx;genetics, genomics and epigenomics-related reagents for research use, including for nucleic acid and protein sample preparation for next-generation sequencing (ngs);research, analytical and consulting services that focus on next-generation sequencing (ngs) and sample preparation therefor,?performance for ngs, and services regarding dna and rna mapping technologies including kas-seq, keth-seq, cap-c, and?services assisting researchers using of ngs technologies; research, analytical and consulting services for medical diagnostic?purposes via laboratory-developed tests (ldts) and fda-approved in vitro diagnostics (ivds); software as a service (saas) services analytic platform focusing on bioinformatics analyses of ngs data for research use only and/or and future medical diagnostic purposes via laboratory-developed tests (ldts) and fda-?approved in vitro diagnostics (ivds);.

Its status is currently believed to be active. Its class is unavailable. “ACCURADX” is believed to be currently owned by “AccuraDX Inc.”